NKMAX Co., Ltd.
Develops NK cell-based therapies, diagnostics, and biological products.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7182400002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
Description
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-01-22 00:00 |
주식매수선택권부여에관한신고
|
Korean | 12.7 KB | ||
| 2020-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2020-12-03 00:00 |
증권발행결과(자율공시)
|
Korean | 5.9 KB | ||
| 2020-11-30 00:00 |
증권발행결과(자율공시)
|
Korean | 5.9 KB | ||
| 2020-11-26 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 48.2 KB | ||
| 2020-11-26 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 36.8 KB | ||
| 2020-11-13 00:00 |
분기보고서 (2020.09)
|
Korean | 1.3 MB | ||
| 2020-10-08 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 48.3 KB | ||
| 2020-10-05 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 130.4 KB | ||
| 2020-09-17 00:00 |
[첨부추가]기업설명회(IR)개최
|
Korean | 7.4 KB | ||
| 2020-08-28 00:00 |
[기재정정]기타경영사항(자율공시)(제6회차 전환사채 취득 후 재매각의 건)
|
Korean | 15.4 KB | ||
| 2020-08-21 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 131.3 KB | ||
| 2020-08-14 00:00 |
반기보고서 (2020.06)
|
Korean | 1.2 MB | ||
| 2020-07-15 00:00 |
기타경영사항(자율공시)(제6회차 전환사채 취득 후 재매각의 건)
|
Korean | 11.4 KB | ||
| 2020-07-06 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 59.4 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NKMAX Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
